Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)

By sjmartinez • May 14, 2024

Razavi AC, Richardson LC, Coronado F, Dzaye O, Bhatia HS, Mehta A, Quyyumi AA, Vaccarino V, Budoff MJ, Nasir K, Tsimikas S, Whelton SP, Blaha MJ, Blumenthal RS, Sperling LS. Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a). Am J Prev Cardiol. 2024 Apr 27;18:100674. doi: 10.1016/j.ajpc.2024.100674. PMID: 38741703; PMCID: PMC11090055.

Tags: Aspirin, Cardiology/Epi, cardiovascular disease, Harbor UCLA, lipoprotein(a), NHANES, Publications

Related Posts

Making a Career to Fight Cancer: Johannes Czernin Talks with Mike Teitell About His Career as a Research Physician

Teitell M, Czernin J. Making a Career to Fight Cancer: Johannes Czernin Talks with Mike Teitell About His Career as a Research Physician. J Nucl[...]

Toward Providing Equitable Care for Adults with Congenital Heart Disease: Where We Are and Where We Need to Be

Lin JP, Marelli A, Liu A, Guo L, Desalvo J, Hile D, Roeder M, Aboulhosn J, Daniels CJ. Toward Providing Equitable Care for Adults with[...]

Oral magnesium and outcomes in US veterans with heart failure

Yin Y, Costello RB, Fonarow GC, Heidenreich PA, Morgan CJ, Faselis C, Cheng Y, Zullo AR, Liu S, Lam PH, Rosanoff A, Vargas JD, Gottlieb[...]